Printer Friendly

ALZA, CYANAMID, ELAN AND MARION MERRELL CONCLUDE AGREEMENTS AND REACH AN OUT-OF-COURT SETTLEMENT

 ALZA, CYANAMID, ELAN AND MARION MERRELL CONCLUDE AGREEMENTS
 AND REACH AN OUT-OF-COURT SETTLEMENT
 WAYNE, N.J., May 28 /PRNewswire/ -- ALZA Corporation (AMEX: AZA), American Cyanamid Company (NYSE: ACY), Elan Corporation plc and Marion Merrell Dow Inc. (NYSE: MKC) announced today that they have concluded agreements and reached an out-of-court settlement concerning patents owned by the parties covering technology for transdermal nicotine systems.
 Elan and Cyanamid have agreed to withdraw their patent infringement suit filed against Marion Merrell Dow and ALZA in the U.S. District Court in San Francisco, and Marion Merrell Dow and ALZA have agreed to withdraw their countersuit against Elan and Cyanamid. The settlement will have no impact on the financial statements of any of the parties. Further details of the settlement were not disclosed.
 Marion Merrell Dow markets Nicoderm(R) nicotine transdermal system, a smoking cessation aid developed by ALZA. American Cyanamid Company's Lederle Laboratories division markets ProStep(TM) nicotine transdermal system, a smoking cessation aid developed by Elan.
 -0- 5/28/92
 /CONTACT: Bonnie Burdett of ALZA, 415-494-5222, or Jeff Hoyak of Cyanamid, 201-831-4619, or Tom Redington of Elan, 203-222-7399, or Dave Thompson of Marion Merrell Dow, 816-966-4000/
 (AZA ACY MKC) CO: American Cyanamid Co.; ALZA Corp.; Elan Corp.; Marion Merrell Dow ST: New Jersey IN: MTC SU:


KD-OS -- NY003 -- 4672 05/28/92 11:00 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 28, 1992
Words:222
Previous Article:ATLAS LAUNCH RESCHEDULED
Next Article:PULLING OUT OF A RECESSION, NEW JERSEY MID-SIZE FIRMS REPORT SO-SO YEAR, LOOK TO IMPROVE AHEAD IN NATWEST SURVEY
Topics:


Related Articles
MARION MERRELL DOW ANNOUNCES SETTLEMENT WITH GENERIC MAKER ON LOOK-ALIKE TABLETS
ELAN: COURT REFUSES TO CONTINUE RESTRAINT AGAINST MARION MERRELL DOW
MARION MERRELL DOW AND RHONE-POULENC RORER REACH AGREEMENT TO SETTLE DISPUTES REGARDING ANTIHYPERTENSIVE DRUGS
MARION MERRELL DOW COMMENTS ON COURT CASE
MARION MERRELL DOW & TANABE SEIYAKU
MARION MERRELL DOW AND TANABE SEIYAKU FILE INTERNATIONAL TRADE COMPLAINT AGAINST CARDIZEM IMITATORS
DILTIAZEM PATENT PROCESS CONFIRMED -- CLEARS WAY FOR MARION MERRELL DOW CASE AT INTERNATIONAL TRADE COMMISSION
COURT RULES IN FAVOR OF ALZA & MARION MERRELL DOW, DECLARES CIBA-GEIGY NICOTINE PATENT INVALID
COURT RULES IN FAVOR OF ALZA & HOECHST MARION ROUSSEL
HOECHST MARION ROUSSEL, ALZA CORPORATION AND CIBA-GEIGY SETTLE NICOTINE PATCH PATENT LITIGATION

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters